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New formulation metered dose inhaler increases 
breath alcohol levels 
P. W. BARRY AND C. O’CALLAGHAN 
Deparfmenf of Child Health, University of Leicesfer, Leicesfer, U.K. 
A new, chlorofluorocarbon-free metered dose inhaler containing salbutamol, with small amounts of ethanol as a 
co-solvent, has recently been released. We evaluated the effect on breath alcohol levels of two inhalations from this 
metered dose inhaler. In 10 volunteers, breath alcohol levels rose to 17.9pg 100 ml- ’ breath after an inhalation with 
a good technique, and to 35 pg 100 ml - ’ breath (the current legal limit for driving in the UK) after a poor 
inhalation. Breath alcohol levels were reduced by the use of a spacer device, and in all cases fell to near zero after 
2 min. In patients who have just used this type of metered dose inhaler, breath alcohol measurements should be 
deferred for at least 2 min. 
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Introduction 
Chlorofluorocarbons (CFCs) are currently used as propel- 
lants in metered dose inhalers. The ozone-depleting poten- 
tial of these chemicals has led to proposals to end their 
production (1). Metered dose inhalers (MDls), which do 
not contain ozone-depleting chemicals, are being developed 
and an MD1 containing salbutamol using the less ozone- 
depleting hydrofluoroalkane HFA 134a has recently been 
launched in the U.K. (Airomir, 3M Pharmaceuticals, 
Loughborough, U.K.). This formulation contains a small 
amount of ethanol as a co-solvent, each actuation deliver- 
ing 4~1 of ethanol. We wished to determine whether use of 
the Airomir MD1 affected measurements of breath alcohol 
levels. 
Methods 
Ten healthy adult volunteers, aged 24-36 years, took part in 
the study in which two breaths of salbutamol (1OOpg per 
actuation from the Airomir MDI) were inhaled on each of 
three different days. None of the subjects were taking 
medication, and none had taken alcohol in the 12 h before 
the test. Prior to starting, breath alcohol levels were 
measured using a Lion Alcolmeter (Lion Laboratories, 
Barry, Wales, U.K.). On 3 separate days, in random order, 
subjects used the metered dose inhaler with good inhaler 
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technique; with poor inhaler technique; or with a spacer 
device. 
To simulate good inhaler technique, subjects were 
instructed to shake the MDI, place the MD1 between their 
lips and inhale, actuating the MD1 at the beginning of 
inhalation. They then held their breath for 10 s, before 
repeating the manoeuvre with a second actuation of the 
MDI. 
To simulate poor inhaler technique, subjects repeated the 
manoeuvre on a separate day, but actuated the MD1 when 
inhalation was completed. They then held their breath for 
10 s, before repeating the manoeuvre. 
To determine the effect of spacer use, Airomir was 
inhaled via an Aerochamber spacer device (Trudell Medi- 
cal, Hamilton, Canada). Subjects were instructed to shake 
the MDI, attach the MD1 to the spacer, place the spacer 
mouthpiece between their lips and inhale, actuating the 
MD1 at the beginning of inhalation. They then held their 
breath for 10 s, before repeating the manoeuvre with a 
second actuation of the MDI. 
In all cases, breath alcohol levels were measured after 
the second inhalation, and again after 2 and 5 min. The 
study was approved by the Leicestershire Ethical Review 
Committee and informed consent was obtained from the 
subjects. 
Results 
The results are shown in Table 1. Breath alcohol levels were 
increased immediately after using the inhaler, from 0 to a 
mean of 17.9 pg 100 ml - ’ breath. This was more marked 
where poor inhaler technique was imitated, breath alcohol 
rising to a mean of 35 pug 100 ml - 1 breath, the current legal 
limit for driving in the U.K. In most subjects, breath 
alcohol levels returned to 0 by 2 min. 
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TABLE 1. Breath alcohol levels @g 100 ml - ’ breath) after using Airomir metered dose inhaler, mean 
and range. A level of 35 pg 100 ml - ’ breath is above the current legal limit for driving in the U.K. 
Time of estimate 
‘Trained inhaler ‘Untrained inhaler 
technique’ technique’ Inhaler + spacer 
Immediately before MD1 use 0.1 (O-l) 0 0 
Immediately after MD1 use 17.9 (7-26) 35 (23-49) 11.4 (5-19) 
2 min after MD1 use 1.5 (O-4) 1.4 (O-4) 1 (O-3 
5 min after MD1 use 0.1 (O-l) 0.5 (O-2) 0 
Discussion 
Use of the Airomir formulation of salbutamol metered dose 
inhaler is not likely to lead to systemic effects of alcohol 
intoxication, as such small volumes of ethanol are deliv- 
ered. However, we have found that use of the Airomir 
inhaler transiently increases breath alcohol levels. We 
assessed the effect of inhalation of two actuations from the 
MDI. Current guidelines for the management of acute 
severe asthma (2) suggest that up to 20 repeated actuations 
may be given, and in this case breath alcohol levels are 
likely to be even higher. The increase in breath alcohol is 
probably due to aerosol impacting in the mouth, as the level 
was greatest when poor inhaler technique was used, and 
was reduced by the use of a spacer device that minimized 
oropharyngeal deposition of aerosol (3). Similar transient 
rises in breath alcohol measurements have been found after 
swilling the mouth with alcohol-containing mouthwashes 
(4). Conventional CFC containing MDIs do not affect 
breath alcohol measurements (5). 
The current legal limit for breath alcohol levels in the 
U.K. is 35 pug 100 ml - i of breath, a level that was exceeded 
by four subjects in this study. Our findings suggest that 
breath alcohol measurements are unreliable as estimates of 
intoxication in patients who have just used their Airomir 
metered dose inhaler. As the effect is transient, it is unlikely 
that use of Airomir could lead to a false prosecution for 
drunken driving or be used in the defence of a drunken 
driver. In patients who have just used their Airomir inhaler, 
breath alcohol measurements should be deferred for at least 
2 min, and others suggest a 15-min period prior to an 
evidential breath test (6). 
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